Dose-Response Study of MR-107A-01 in The Treatment of Post-Surgical Dental Pain

Status:
Completed

Trial end date:
2020-12-22

Target enrollment:

Participant gender:

MR-107A-01 is being studied to investigate its efficacy, safety, and dose-response after dental surgery.

Phase 2

Mylan Inc.